GSK beat profit expectations in the fourth quarter, driven by demand for its HIV drugs and Asthma medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results